Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26.5M
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
5.91M
-
Shares change
-
+1.48M
-
Total reported value, excl. options
-
$82.5M
-
Value change
-
+$20.9M
-
Put/Call ratio
-
1.26
-
Number of buys
-
49
-
Number of sells
-
-13
-
Price
-
$13.97
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q1 2023
79 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q1 2023.
AVITA Medical, Inc. - Common Stock (RCEL) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.91M shares
of 26.5M outstanding shares and own 22.31% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.21M shares), PURA VIDA INVESTMENTS, LLC (799K shares), BlackRock Inc. (483K shares), MILLENNIUM MANAGEMENT LLC (335K shares), EAM Investors, LLC (255K shares), GEODE CAPITAL MANAGEMENT, LLC (250K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (230K shares), RENAISSANCE TECHNOLOGIES LLC (212K shares), Invesco Ltd. (151K shares), and JANE STREET GROUP, LLC (141K shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.